Moderna – MRNA: Kaufsignal bei der Corona-Aktie!
Momentum im Biotech-Sektor! Anleger erwarten bei Moderna Fortschritte in der Forschung, bei klinischen Studien, Zulassungen und der Kommerzialisierung neuer Produkte! ...
Thursday, July 16, 2026
Tag: Moderna
Moderna (MRNA) Has a Cash Runway and Pipeline Story Bigger Than the Post-COVID Collapse Label
Moderna, Inc. (MRNA) is still discussed in many investor conversations as if the story ended when pandemic-era COVID vaccine revenues ...
Roivant anticipates $950M Moderna payment in July as it outlines 2H 2026 mosliciguat and IMVT-1402 readouts (NASDAQ:ROIV)
Earnings Call Insights: Roivant Sciences Ltd. (ROIV) Q4 2025 Management View CEO Matthew Gline said the quarter included “the preliminary ...
Moderna Stock Is Surging on Hantavirus Threats. Its Chart Offers a Harsh Dose of Reality.
The Covid-19 pandemic, which consumed every moment of our waking days and claimed over 1 million lives in the U.S. ...
Moderna – MRNA: Impfstoff-Aktie mit mega-starkem Comeback!
+ 100 Prozent in 6 Monaten! mrRNA-Impfstoffe gegen Krebs, Grippe & RSV bei Moderna in der Pipeline! Neue Rallye trotz ...
1 Stock to Buy, 1 Stock to Sell This Week: Cisco, Moderna
U.S. jobs report, CPI inflation data, retail sales, and more earnings will be in focus this week. Cisco is projected ...
Moderna faces $5 billion mRNA patent lawsuit after ‘Star Trek’ ruling
Behind the household COVID-19 name, Moderna, is facing a $5 billion patent-infringement lawsuit over vaccine technology. On February 2, 2026, ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.